Kubarikov P G, Davidov M I
Khirurgiia (Mosk). 1991 Jul(7):76-8.
In massive blood loss (1,000-4,900 ml) during operations on the kidneys and prostate in 42 patients, 900 to 3,600 ml of blood was reinfused. Thirty-seven (88.1%) patients recovered. Fatal outcomes in 5 cases were caused by complications of the principal and concomitant diseases and were unrelated to blood reinfusion. Study of the morphological, biochemical, and coagulation properties of the patients' blood showed gradual restoration of hemostatic values and no harmful effect of the reinfusion on the organism. The authors claim that blood reinfusion can be undertaken in operations on the kidneys and prostate when there are vital indications. Kidney tumors are a relative contraindication for reinfusion. Blood reinfusion is not indicated in purulent diseases of the kidneys.
在42例肾脏和前列腺手术中出现大量失血(1000 - 4900毫升)的患者中,回输了900至3600毫升血液。37例(88.1%)患者康复。5例死亡病例是由主要疾病和伴随疾病的并发症导致的,与血液回输无关。对患者血液的形态学、生化和凝血特性研究表明,止血指标逐渐恢复,回输对机体无有害影响。作者声称,在有重要指征时,肾脏和前列腺手术中可进行血液回输。肾脏肿瘤是血液回输的相对禁忌证。肾脏化脓性疾病不适合进行血液回输。